**Interest Rate Swap Contract**

This contract is an interest rate swap between two parties, Party1 and Party2, with a notional amount of USD 10,000,000. The contract has a fixed rate of 4.427% per annum for Party A (Party1) and a floating rate based on USD SOFR-Compound for Party B (Party2).

**General Terms**

* Trade Date: 2018-04-01
* Effective Date: 2018-04-03
* Termination Date: 2026-02-08
* Mandatory Early Termination Date: 2023-11-03
* Business Day Convention: Modified Following
* Fixing Business Days: US Government Bonds Market
* Business Days: New York
* Calculation Agent: Party1 (unless stated otherwise in ISDA)
* Governing Law: English
* Documentation: ISDA

**Party A Payments**

* Party A pays (in USD): 4.427% p.a. on the USD Notional Amount
* Party A Calculation Period: From and including the Effective Date to, but excluding, the Termination Date
* Party A Payment Dates: Annually 2 Business Days after the 5th of October of each year, commencing on 7th October 2024, up to and including 7th October 2033
* Party A Day Count: ACT/360, Adjusted

**Party B Payments**

* Party B pays (in USD): USD SOFR-Compound p.a. on the USD Notional Amount
* Party B Calculation Period: From and including the Effective Date to, but excluding, the Termination Date
* Party B Payment Dates: Annually 2 Business Days after the 5th of October of each year, commencing on 7th October 2024, up to and including 7th October 2033
* Party B Day Count: ACT/360, Adjusted

**Mandatory Early Termination Clause**

* The swap shall be terminated on the Mandatory Early Termination Date at the market value of the swap, as on the Mandatory Early Termination Date, subject to adjustment in accordance with the Modified Following Business Day Convention.
* On 2 Business Days after the Mandatory Early Termination Date, the party which is out-of-the-money shall pay to the party which is in-the-money, the Cash Settlement Amount, which shall be an amount in USD equal to the absolute value of the market value of the swap, as determined on the Mandatory Early Termination Date.

**Risk Disclosure**

* There are significant risks associated with this Transaction, including, but not limited to, foreign exchange risk, price risk, liquidity risk, and credit risk.
* Counterparties should consult their own financial, legal, accounting, and tax advisors about the risks associated with this Transaction, the appropriate tools to analyze the Transaction, and the suitability of the Transaction in each counterparty's particular circumstances.

**Scenario Analysis**

* The following Scenario Analysis is provided for illustrative and convenience purposes only. It should not be relied on by Party B, and Party1 expressly disclaims any responsibility or reliance by Party B.
* Scenario 1: USD SOFR-Compound remains unchanged over the tenor of the trade.
* Scenario 2: USD SOFR-Compound increases over the tenor of the trade.
* Scenario 3: USD SOFR-Compound decreases over the tenor of the trade.

**Mark to Market (MTM) Sensitivity Analysis**

* The following MTM Analysis is provided for illustrative and convenience purposes only. It should not be relied on by Party B, and Party1 expressly disclaims any responsibility or reliance by Party B.
* MTM Sensitivity due to parallel shift in USD SOFR-Compound Curve immediately after Trade Date.
* MTM Sensitivity due to parallel shift in USD SOFR-Compound Curve as on Mandatory Termination Date compared to Trade Date.

**Level of Pricing Variables and Impact of Variables on Pricing**

* The following analysis is provided for information and illustrative purposes only. All information provided herein is indicative, non-exhaustive, and is based on certain assumptions and current market conditions and is subject to change without notice.
* The market level of primary market variables used in determining the price of the transaction is as follows:
	+ USD 10-year SOFR-Compound Rate: 4.427%

**Representations**

* Each party represents to the other party on the date on which it enters into this Transaction that (absent a written agreement between the parties in respect of this Transaction that expressly imposes affirmative obligations to the contrary):
	+ It is acting for its own account, and it has made its own independent decisions to enter into this Transaction and as to whether this Transaction is appropriate or proper for it based upon its own judgment and upon advice from such tax, accounting, regulatory, legal, and financial advisers as it has deemed necessary.
	+ It is capable of assessing the merits of and understanding (on its own behalf or through independent professional advice), and understands and accepts, the terms, conditions, and risks of this Transaction.
	+ The other party is not acting as a fiduciary for, or an adviser to it in respect of this Transaction.
	+ This Transaction is subject at all times, to the applicable laws, including but not limited to the Reserve Bank of India (“RBI”) and the Foreign Exchange Management Act, 1999, rules, regulations, and guidelines issued thereunder, as may be amended from time to time (collectively, the “Regulations”) and does not contravene any of the said Regulations.

**Counterparty Representations**

* Party B represents and confirms to Party1 as follows:
	+ It has the power to enter into this Transaction and to deliver any document relating to this Transaction and to perform its obligations under this Transaction and has taken all necessary action to authorize such execution, delivery, and performance.
	+ All necessary governmental and other consents that are required to have been obtained by it with respect to this Transaction (or any part thereof) have been obtained and are in full force and effect and all conditions of any such consents have been (and shall continue to be) complied with.
	+ Its entry into and performance of its obligations under this Transaction does not and will not result in a breach or violation of any applicable law or regulation.
	+ That it is entering into this Transaction solely for the purpose of hedging its underlying exposure (“Underlying Exposure”) and not for purposes of speculation, and the size and tenure of this Transaction is not in excess of Party B’s Underlying Exposure.
	+ This Transaction has been booked against the said Underlying Exposure and the Underlying Documents in respect of the said Underlying Exposure have been/ will be provided to Party1 by Party B.
	+ It has familiarized itself and fully understood the above terms and conditions and accepts the risks of entering into this Transaction.